gliotaz TEMOZOLOMIDE

Introduction to gliotaz

Gliotaz is a medication available in tablet form, primarily used to treat certain brain tumors. Gliotaz is effective against aggressive types of cancer, such as glioblastoma multiforme and anaplastic astrocytoma, which affect the brain.

Composition of gliotaz

Gliotaz contains the active ingredient Temozolomide, which belongs to a class of drugs known as alkylating agents. These agents work by adding an alkyl group to the DNA of cancer cells, causing damage and preventing them from growing and dividing.

Uses of gliotaz

• Treatment of glioblastoma multiforme
• Treatment of anaplastic astrocytoma

Side effects of gliotaz

• Common side effects: nausea, vomiting, fatigue
• Serious side effects: lowered blood cell counts, increased risk of infection

Precautions of gliotaz

Patients should be aware that gliotaz can lower blood cell counts, increasing the risk of infection. It is not recommended for use during pregnancy due to potential harm to the unborn baby. Patients with severe bone marrow suppression should avoid using gliotaz.

How to Take gliotaz

Gliotaz is taken orally, usually starting at a dose of 150 mg/m² once daily for five days in a 28-day cycle. It should be taken on an empty stomach, either one hour before or two hours after a meal. Always follow your doctor's advice for the correct usage.

Conclusion of gliotaz

Gliotaz, containing the active ingredient Temozolomide, is part of the alkylating agents therapeutic class. It is primarily used to treat aggressive brain tumors like glioblastoma multiforme and anaplastic astrocytoma. Manufactured with precision, gliotaz is a key player in cancer treatment. Always consult your healthcare provider for personalized advice and information about gliotaz.